| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Patient Protection and Affordable Care Act | 10 | 2019 | 164 | 4.42 | Why? |
| Medicare | 18 | 2019 | 1048 | 3.97 | Why? |
| Pain Management | 13 | 2020 | 854 | 3.96 | Why? |
| Low Back Pain | 6 | 2019 | 190 | 3.32 | Why? |
| Vertebroplasty | 7 | 2018 | 14 | 3.27 | Why? |
| Chronic Pain | 11 | 2020 | 736 | 2.81 | Why? |
| Spinal Fractures | 7 | 2018 | 124 | 2.49 | Why? |
| Osteoporotic Fractures | 6 | 2018 | 175 | 2.22 | Why? |
| Radiologists | 7 | 2020 | 873 | 2.12 | Why? |
| Physician Incentive Plans | 5 | 2017 | 18 | 1.88 | Why? |
| Back Pain | 5 | 2019 | 115 | 1.86 | Why? |
| Injections, Epidural | 4 | 2020 | 45 | 1.86 | Why? |
| Radiology | 13 | 2020 | 1199 | 1.83 | Why? |
| Fractures, Compression | 4 | 2018 | 33 | 1.76 | Why? |
| Stroke | 24 | 2021 | 8839 | 1.66 | Why? |
| Brain Ischemia | 12 | 2021 | 2813 | 1.57 | Why? |
| Thrombectomy | 17 | 2021 | 2272 | 1.55 | Why? |
| Medicare Access and CHIP Reauthorization Act of 2015 | 4 | 2018 | 4 | 1.24 | Why? |
| Anesthetics, Local | 3 | 2020 | 205 | 1.21 | Why? |
| Prospective Payment System | 4 | 2018 | 28 | 1.18 | Why? |
| Medicaid | 4 | 2017 | 492 | 1.15 | Why? |
| Kyphoplasty | 4 | 2018 | 13 | 1.09 | Why? |
| Intracranial Aneurysm | 5 | 2018 | 504 | 0.93 | Why? |
| Reimbursement Mechanisms | 4 | 2018 | 243 | 0.92 | Why? |
| Bone Cements | 2 | 2018 | 21 | 0.91 | Why? |
| Health Expenditures | 7 | 2018 | 904 | 0.91 | Why? |
| Intervertebral Disc Displacement | 2 | 2018 | 25 | 0.87 | Why? |
| Employee Performance Appraisal | 2 | 2016 | 15 | 0.85 | Why? |
| Fee Schedules | 3 | 2018 | 13 | 0.85 | Why? |
| Regenerative Medicine | 2 | 2019 | 161 | 0.81 | Why? |
| Analgesics, Opioid | 3 | 2018 | 1070 | 0.77 | Why? |
| Pedicle Screws | 1 | 2018 | 16 | 0.74 | Why? |
| Cord Blood Stem Cell Transplantation | 1 | 2020 | 143 | 0.74 | Why? |
| Cerebral Revascularization | 1 | 2018 | 45 | 0.74 | Why? |
| Intervertebral Disc | 1 | 2018 | 16 | 0.74 | Why? |
| Diagnostic Imaging | 5 | 2018 | 1044 | 0.73 | Why? |
| Polymethyl Methacrylate | 1 | 2018 | 51 | 0.71 | Why? |
| United States | 37 | 2020 | 46150 | 0.71 | Why? |
| Platelet-Rich Plasma | 1 | 2018 | 91 | 0.70 | Why? |
| Game Theory | 1 | 2017 | 36 | 0.70 | Why? |
| Neuroimaging | 3 | 2020 | 1106 | 0.69 | Why? |
| Physician Executives | 1 | 2018 | 71 | 0.69 | Why? |
| Medicare Payment Advisory Commission | 2 | 2018 | 3 | 0.69 | Why? |
| Spinal Stenosis | 1 | 2017 | 22 | 0.69 | Why? |
| Mesenchymal Stem Cell Transplantation | 2 | 2020 | 1322 | 0.69 | Why? |
| Zygapophyseal Joint | 2 | 2017 | 16 | 0.68 | Why? |
| Opioid-Related Disorders | 3 | 2018 | 1185 | 0.68 | Why? |
| Professional Practice Location | 1 | 2017 | 31 | 0.68 | Why? |
| Reimbursement, Incentive | 2 | 2017 | 70 | 0.67 | Why? |
| Endovascular Procedures | 9 | 2020 | 1302 | 0.67 | Why? |
| Placebo Effect | 1 | 2017 | 108 | 0.66 | Why? |
| Nerve Block | 3 | 2017 | 183 | 0.66 | Why? |
| Cancer Pain | 1 | 2018 | 91 | 0.65 | Why? |
| Neurologists | 1 | 2020 | 283 | 0.65 | Why? |
| Journal Impact Factor | 4 | 2019 | 134 | 0.64 | Why? |
| Statistics as Topic | 1 | 2019 | 370 | 0.64 | Why? |
| Specialization | 2 | 2017 | 432 | 0.63 | Why? |
| Neck Pain | 1 | 2017 | 126 | 0.62 | Why? |
| Pain Measurement | 3 | 2018 | 533 | 0.61 | Why? |
| Neurosurgeons | 2 | 2017 | 396 | 0.59 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.58 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.58 | Why? |
| Neurology | 4 | 2020 | 1613 | 0.56 | Why? |
| Spinal Puncture | 1 | 2014 | 95 | 0.54 | Why? |
| Certification | 2 | 2017 | 261 | 0.54 | Why? |
| Bibliometrics | 5 | 2019 | 731 | 0.52 | Why? |
| Cost-Benefit Analysis | 3 | 2019 | 2259 | 0.52 | Why? |
| Physicians | 4 | 2018 | 4214 | 0.52 | Why? |
| Health Care Reform | 2 | 2017 | 409 | 0.50 | Why? |
| Neurosurgical Procedures | 4 | 2020 | 1738 | 0.49 | Why? |
| Health Care Costs | 3 | 2018 | 1007 | 0.44 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.44 | Why? |
| Insurance, Health | 1 | 2017 | 634 | 0.44 | Why? |
| Quality Improvement | 3 | 2018 | 2435 | 0.44 | Why? |
| Hospital Administration | 1 | 2017 | 650 | 0.43 | Why? |
| Neurosurgery | 2 | 2020 | 1585 | 0.42 | Why? |
| Federal Government | 1 | 2017 | 562 | 0.42 | Why? |
| Intersectoral Collaboration | 1 | 2017 | 1065 | 0.42 | Why? |
| Arterial Occlusive Diseases | 3 | 2020 | 363 | 0.39 | Why? |
| Patients' Rooms | 1 | 2014 | 675 | 0.39 | Why? |
| Pain | 2 | 2017 | 1084 | 0.39 | Why? |
| Fibrinolytic Agents | 3 | 2019 | 1702 | 0.37 | Why? |
| Fee-for-Service Plans | 3 | 2018 | 144 | 0.37 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.36 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.36 | Why? |
| Humans | 94 | 2021 | 930598 | 0.35 | Why? |
| Hemostasis | 1 | 2014 | 811 | 0.35 | Why? |
| Anesthesiology | 1 | 2018 | 1163 | 0.34 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.34 | Why? |
| Hospital Units | 1 | 2014 | 1017 | 0.33 | Why? |
| Health Policy | 2 | 2018 | 6242 | 0.33 | Why? |
| Injections, Intra-Articular | 2 | 2020 | 104 | 0.33 | Why? |
| Aneurysm, Ruptured | 2 | 2018 | 109 | 0.32 | Why? |
| Politics | 2 | 2017 | 1824 | 0.32 | Why? |
| Education, Medical, Continuing | 1 | 2013 | 638 | 0.31 | Why? |
| Review Literature as Topic | 1 | 2009 | 387 | 0.30 | Why? |
| Quality of Health Care | 2 | 2017 | 1948 | 0.30 | Why? |
| Randomized Controlled Trials as Topic | 6 | 2020 | 10649 | 0.30 | Why? |
| Stents | 4 | 2018 | 916 | 0.30 | Why? |
| Efficiency | 2 | 2020 | 420 | 0.30 | Why? |
| Consensus | 2 | 2018 | 6345 | 0.30 | Why? |
| Research Design | 2 | 2019 | 5830 | 0.29 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.29 | Why? |
| Attitude of Health Personnel | 2 | 2020 | 4741 | 0.28 | Why? |
| Health Care Surveys | 1 | 2014 | 2942 | 0.28 | Why? |
| Embolization, Therapeutic | 2 | 2017 | 269 | 0.26 | Why? |
| Biological Products | 1 | 2019 | 2331 | 0.26 | Why? |
| Radiology, Interventional | 2 | 2020 | 398 | 0.26 | Why? |
| Magnetic Resonance Imaging | 6 | 2020 | 6551 | 0.26 | Why? |
| Elective Surgical Procedures | 2 | 2020 | 5338 | 0.25 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.25 | Why? |
| Clinical Trials as Topic | 3 | 2019 | 7330 | 0.24 | Why? |
| Lumbar Vertebrae | 3 | 2018 | 196 | 0.24 | Why? |
| Meta-Analysis as Topic | 1 | 2009 | 1289 | 0.24 | Why? |
| Pneumonia, Viral | 12 | 2020 | 243684 | 0.21 | Why? |
| Coronavirus Infections | 12 | 2020 | 253789 | 0.21 | Why? |
| Pandemics | 14 | 2020 | 389249 | 0.20 | Why? |
| Intervertebral Disc Chemolysis | 1 | 2018 | 3 | 0.20 | Why? |
| Bone Screws | 1 | 2018 | 30 | 0.19 | Why? |
| Advisory Committees | 2 | 2017 | 1418 | 0.19 | Why? |
| Cementoplasty | 1 | 2018 | 3 | 0.19 | Why? |
| Central Nervous System Depressants | 1 | 2018 | 52 | 0.19 | Why? |
| Delivery of Health Care | 3 | 2020 | 15909 | 0.18 | Why? |
| Heroin | 1 | 2018 | 41 | 0.18 | Why? |
| Basilar Artery | 1 | 2017 | 31 | 0.18 | Why? |
| Sacroiliac Joint | 1 | 2017 | 26 | 0.18 | Why? |
| Sacrum | 1 | 2018 | 41 | 0.18 | Why? |
| Injections, Spinal | 1 | 2017 | 61 | 0.18 | Why? |
| Cerebral Arteries | 1 | 2018 | 90 | 0.18 | Why? |
| Spinal Neoplasms | 1 | 2018 | 95 | 0.17 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.17 | Why? |
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 98 | 0.17 | Why? |
| Cost Control | 1 | 2017 | 35 | 0.17 | Why? |
| Umbilical Cord | 1 | 2020 | 358 | 0.17 | Why? |
| Prescription Drug Misuse | 1 | 2018 | 54 | 0.17 | Why? |
| Anticoagulants | 1 | 2019 | 9563 | 0.17 | Why? |
| Analgesia, Epidural | 1 | 2017 | 63 | 0.17 | Why? |
| Reoperation | 2 | 2018 | 544 | 0.17 | Why? |
| Analgesia | 1 | 2020 | 211 | 0.17 | Why? |
| Value-Based Purchasing | 1 | 2017 | 26 | 0.17 | Why? |
| Fracture Fixation, Internal | 1 | 2018 | 188 | 0.16 | Why? |
| Surveys and Questionnaires | 4 | 2020 | 43792 | 0.16 | Why? |
| United States Dept. of Health and Human Services | 1 | 2017 | 71 | 0.16 | Why? |
| Vasospasm, Intracranial | 1 | 2017 | 50 | 0.16 | Why? |
| Sample Size | 1 | 2019 | 518 | 0.16 | Why? |
| Carotid Arteries | 1 | 2018 | 182 | 0.16 | Why? |
| Mechanical Thrombolysis | 1 | 2017 | 150 | 0.16 | Why? |
| Fentanyl | 1 | 2018 | 142 | 0.16 | Why? |
| Treatment Outcome | 11 | 2021 | 51732 | 0.16 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.16 | Why? |
| Cervical Vertebrae | 1 | 2017 | 151 | 0.16 | Why? |
| Evidence-Based Medicine | 1 | 2009 | 3228 | 0.15 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.15 | Why? |
| Societies, Medical | 3 | 2018 | 6907 | 0.15 | Why? |
| Practice Management, Medical | 1 | 2018 | 118 | 0.15 | Why? |
| Neurosciences | 1 | 2017 | 148 | 0.15 | Why? |
| Operative Time | 1 | 2017 | 450 | 0.15 | Why? |
| Suction | 1 | 2017 | 297 | 0.14 | Why? |
| Multidetector Computed Tomography | 1 | 2018 | 307 | 0.14 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2020 | 663 | 0.14 | Why? |
| Costs and Cost Analysis | 1 | 2019 | 694 | 0.14 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.13 | Why? |
| Vasodilator Agents | 1 | 2017 | 344 | 0.13 | Why? |
| Administrative Personnel | 1 | 2017 | 326 | 0.13 | Why? |
| Lumbosacral Region | 1 | 2012 | 30 | 0.13 | Why? |
| Fluoroscopy | 1 | 2013 | 140 | 0.13 | Why? |
| Probability | 1 | 2017 | 923 | 0.12 | Why? |
| Ethanol | 1 | 2018 | 533 | 0.12 | Why? |
| Needles | 1 | 2013 | 87 | 0.12 | Why? |
| Insurance Coverage | 1 | 2017 | 348 | 0.12 | Why? |
| Spinal Cord Diseases | 1 | 2013 | 141 | 0.12 | Why? |
| Observer Variation | 2 | 2017 | 622 | 0.12 | Why? |
| Radiology Department, Hospital | 1 | 2020 | 805 | 0.11 | Why? |
| Publishing | 2 | 2020 | 990 | 0.11 | Why? |
| Angioplasty, Balloon | 1 | 2011 | 66 | 0.11 | Why? |
| Drug Overdose | 1 | 2018 | 583 | 0.11 | Why? |
| Practice Patterns, Physicians' | 3 | 2019 | 4927 | 0.11 | Why? |
| Cancer Survivors | 1 | 2018 | 588 | 0.11 | Why? |
| Patient Transfer | 1 | 2018 | 898 | 0.11 | Why? |
| Triage | 2 | 2020 | 7151 | 0.11 | Why? |
| United States Food and Drug Administration | 1 | 2018 | 1276 | 0.11 | Why? |
| Subarachnoid Hemorrhage | 1 | 2017 | 611 | 0.11 | Why? |
| Male | 20 | 2020 | 367725 | 0.11 | Why? |
| Graft Occlusion, Vascular | 1 | 2011 | 105 | 0.11 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.10 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.10 | Why? |
| Thrombolytic Therapy | 2 | 2019 | 2218 | 0.10 | Why? |
| Disease Management | 2 | 2019 | 6841 | 0.10 | Why? |
| Continuity of Patient Care | 1 | 2020 | 1574 | 0.10 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.10 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.10 | Why? |
| Retrospective Studies | 14 | 2019 | 105322 | 0.10 | Why? |
| Databases, Factual | 3 | 2019 | 6248 | 0.09 | Why? |
| Cerebrovascular Disorders | 1 | 2017 | 1040 | 0.09 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.09 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.09 | Why? |
| Carotid Stenosis | 1 | 2011 | 207 | 0.09 | Why? |
| Carotid Artery Diseases | 1 | 2011 | 251 | 0.09 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.09 | Why? |
| Periodicals as Topic | 2 | 2020 | 1492 | 0.09 | Why? |
| Tomography, X-Ray Computed | 4 | 2020 | 25144 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
| Telephone | 1 | 2017 | 1705 | 0.09 | Why? |
| Aged | 14 | 2020 | 215776 | 0.09 | Why? |
| Research | 1 | 2020 | 2115 | 0.08 | Why? |
| Workload | 1 | 2018 | 1887 | 0.08 | Why? |
| Female | 19 | 2020 | 380317 | 0.08 | Why? |
| Hemorrhage | 1 | 2019 | 3013 | 0.08 | Why? |
| Cerebral Angiography | 2 | 2017 | 391 | 0.07 | Why? |
| Universities | 1 | 2020 | 4374 | 0.07 | Why? |
| Data Interpretation, Statistical | 1 | 2009 | 657 | 0.07 | Why? |
| Algorithms | 2 | 2019 | 7346 | 0.07 | Why? |
| Leadership | 1 | 2018 | 2241 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2017 | 2517 | 0.07 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Adult | 8 | 2020 | 244371 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Tissue Plasminogen Activator | 2 | 2019 | 778 | 0.06 | Why? |
| Aged, 80 and over | 5 | 2018 | 88759 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| Europe | 1 | 2018 | 12702 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Current Procedural Terminology | 1 | 2019 | 10 | 0.05 | Why? |
| Middle Aged | 11 | 2019 | 270681 | 0.05 | Why? |
| Students, Medical | 1 | 2019 | 4032 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Intracranial Hemorrhages | 2 | 2019 | 1170 | 0.05 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.05 | Why? |
| Group Practice | 1 | 2018 | 13 | 0.05 | Why? |
| Gels | 1 | 2018 | 111 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Internship and Residency | 1 | 2019 | 4987 | 0.04 | Why? |
| Clinical Protocols | 1 | 2009 | 2734 | 0.04 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.04 | Why? |
| Infusions, Intra-Arterial | 1 | 2017 | 36 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2013 | 15421 | 0.04 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.04 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.04 | Why? |
| Middle Cerebral Artery | 1 | 2017 | 128 | 0.04 | Why? |
| Network Meta-Analysis | 1 | 2018 | 426 | 0.04 | Why? |
| Ultrasonography, Doppler, Transcranial | 1 | 2017 | 143 | 0.04 | Why? |
| Radiography, Interventional | 1 | 2018 | 158 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Organizational Case Studies | 1 | 2017 | 293 | 0.04 | Why? |
| Private Practice | 1 | 2018 | 203 | 0.04 | Why? |
| Reperfusion | 1 | 2017 | 491 | 0.04 | Why? |
| Administration, Intravenous | 1 | 2019 | 1115 | 0.04 | Why? |
| Disability Evaluation | 1 | 2018 | 671 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.03 | Why? |
| Incidental Findings | 1 | 2018 | 487 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.03 | Why? |
| Cerebrovascular Circulation | 1 | 2017 | 340 | 0.03 | Why? |
| Boston | 1 | 2017 | 929 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Efficiency, Organizational | 1 | 2017 | 482 | 0.03 | Why? |
| Massachusetts | 1 | 2018 | 1279 | 0.03 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.03 | Why? |
| Radiography | 1 | 2019 | 1576 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Program Development | 1 | 2017 | 1089 | 0.03 | Why? |
| Prosthesis Failure | 1 | 2011 | 195 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Data Collection | 1 | 2019 | 1769 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Reconstructive Surgical Procedures | 1 | 2018 | 860 | 0.02 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.02 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 226 | 0.02 | Why? |
| Trauma Centers | 1 | 2017 | 1195 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Multicenter Studies as Topic | 1 | 2013 | 2437 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
| Australia | 1 | 2019 | 6306 | 0.02 | Why? |
| Canada | 1 | 2018 | 6018 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Brain | 1 | 2020 | 5133 | 0.02 | Why? |
| Recurrence | 1 | 2011 | 3675 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2011 | 7268 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Animals | 1 | 2013 | 78931 | 0.00 | Why? |